Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
S100A5 Attenuates Efficiency of Anti-PD-L1/PD-1 Immunotherapy by Inhibiting CD8+ T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma.
Adv Sci (Weinh). 2023 Sep;10(25):e2300110. doi: 10.1002/advs.202300110. Epub 2023 Jul 6.
Adv Sci (Weinh). 2023.
PMID: 37414584
Free PMC article.
BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti-PD-1/PD-L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity.
Cai Z, Chen J, Yu Z, Li H, Liu Z, Deng D, Liu J, Chen C, Zhang C, Ou Z, Chen M, Hu J, Zu X.
Cai Z, et al.
Adv Sci (Weinh). 2023 Mar;10(8):e2207155. doi: 10.1002/advs.202207155. Epub 2023 Jan 15.
Adv Sci (Weinh). 2023.
PMID: 36642843
Free PMC article.
Item in Clipboard
Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion.
Chen J, Sun Y, Ou Z, Yeh S, Huang CP, You B, Tsai YC, Sheu TJ, Zu X, Chang C.
Chen J, et al.
EMBO Rep. 2020 Apr 3;21(4):e48467. doi: 10.15252/embr.201948467. Epub 2020 Feb 13.
EMBO Rep. 2020.
PMID: 32052578
Free PMC article.
Item in Clipboard
Cite
Cite